The experience of canakinumab in renal amyloidosis secondary to Familial Mediterranean fever

被引:18
作者
Betul Sozeri
Nesrin Gulez
Malik Ergin
Erkin Serdaroglu
机构
[1] Ege University Faculty of Medicine,Department of Pediatric Rheumatology
[2] Dr. Behcet Uz Children Diseases Teaching and Research Hospital Pediatric Immunology and Rheumatology,undefined
[3] Dr. Behcet Uz Children Diseases Teaching and Research Hospital Pathology,undefined
[4] Dr. Behcet Uz Children Diseases Teaching and Research Hospital Pediatric Nephrology,undefined
关键词
Familial Mediterranean fever; Amyloidosis; Child; Canakinumab;
D O I
10.1186/s40348-016-0058-2
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 175 条
[1]  
Ben-Zvi I(2011)Chronic inflammation in FMF: markers, risk factors, outcomes and therapy Nat Rev Rheumatol 7 105-112
[2]  
Livneh A(1997)Ancient missense mutations in a new member of the RoRet gene family are likely to cause familial Mediterranean fever Cell 90 797-97
[3]  
Grattagliano I(1997)A candidate gene for familial Mediterranean fever Nat Genet 17 25-147
[4]  
Bonfrate L(2014)Novel therapeutics for the treatment of familial Mediterranean fever: from colchicine to biologics Clin Pharmacol Ther 95 89-596
[5]  
Ruggiero V(2014)A clinical guide to autoinflammatory diseases: Familial Mediterranean fever and next-of-kin Nat Rev Rheumatol 10 135-391
[6]  
Scaccianoce G(2003)Molecular mechanisms of amyloidosis N Engl J Med 349 583-685
[7]  
Palasciano G(2013)Evidence-based recommendations for the practical management of Familial Mediterranean fever Semin Arthritis Rheum 43 387-282
[8]  
Portincasa P(2013)Treatment of autoinflammatory diseases: results from the Eurofever Registry and a literature review Ann Rheum Dis 72 678-163
[9]  
Ozen S(2004)Colchicine nonresponsiveness in familial Mediterranean fever: clinical, genetic, pharmacokinetic, and socioeconomic characterization Semin Arthritis Rheum 33 273-678
[10]  
Bilginer Y(2010)Targeting IL-1beta in disease; the expanding role of NLRP3 inflammasome Eur J Intern Med 21 157-31